SunTrust Robinson Humphrey analyst, Edward Nash, reiterated his Buy rating on shares of Viking Therapeutic (NASDAQ: VKTX) after the company ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Viking Therapeutics (VKTX) Announces Proposed Common Share OfferingSeptember 19, 2018 4:23 PM Viking Therapeutic (VKTX) PT Raised to $28 at SunTrust Robinson HumphreySeptember 18, 2018 3:39 PM Viking Therapeutic (VKTX) PT Raised to $28 at Maxim Group, Matching 'Street High'September 18, 2018 12:31 PM Viking Therapeutic (VKTX) PT Raised to 'Street High' $28 at H.C. WainwrightSeptember 18, 2018 11:57 AM